ANXA4 and hepatocellular carcinoma: Comparative statistics between serum levels of AFP and ANXA4 in the 3 studied groups are shown in Table 2: regarding to ANXA4, it showed a significantly higher levels in patients with HCC compared with patients with LC (p < 0.05) and compared with controls (p < 0.05).